RPRX logo

Royalty Pharma (RPRX) Cash From Financing

Annual CFF

$361.14 M
+$2.51 B+116.81%

December 31, 2024


Summary


Performance

RPRX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXcash flowmetrics:

Quarterly CFF

-$257.96 M
+$67.54 M+20.75%

December 31, 2024


Summary


Performance

RPRX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXcash flowmetrics:

TTM CFF

$361.14 M
-$26.07 M-6.73%

December 31, 2024


Summary


Performance

RPRX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

RPRX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+116.8%-11.2%+116.8%
3 y3 years-6.2%-11.2%+116.8%
5 y5 years+130.3%-11.2%+116.8%

RPRX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6.2%+116.8%-122.3%+81.0%-7.6%+116.5%
5 y5-year-75.7%+116.8%-116.3%+81.0%-76.8%+116.5%
alltimeall time-75.7%+116.8%-116.3%+81.0%-76.8%+116.5%

Royalty Pharma Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$361.14 M(-116.8%)
-$257.96 M(-20.7%)
$361.14 M(-6.7%)
Sep 2024
-
-$325.50 M(-128.1%)
$387.21 M(-159.9%)
Jun 2024
-
$1.16 B(-645.6%)
-$646.77 M(-69.9%)
Mar 2024
-
-$212.00 M(-8.6%)
-$2.15 B(+0.1%)
Dec 2023
-$2.15 B(+127.4%)
-$231.89 M(-82.9%)
-$2.15 B(-1.5%)
Sep 2023
-
-$1.36 B(+291.8%)
-$2.18 B(+107.3%)
Jun 2023
-
-$347.00 M(+64.9%)
-$1.05 B(+12.7%)
Mar 2023
-
-$210.37 M(-20.8%)
-$934.26 M(-1.1%)
Dec 2022
-$944.86 M(-345.3%)
-$265.55 M(+15.4%)
-$944.86 M(+7.7%)
Sep 2022
-
-$230.09 M(+0.8%)
-$877.38 M(-326.7%)
Jun 2022
-
-$228.25 M(+3.3%)
$386.98 M(-1.0%)
Mar 2022
-
-$220.97 M(+11.6%)
$390.82 M(+1.5%)
Dec 2021
$385.11 M
-$198.07 M(-119.2%)
$385.11 M(+25.9%)
DateAnnualQuarterlyTTM
Sep 2021
-
$1.03 B(-560.9%)
$305.79 M(-128.2%)
Jun 2021
-
-$224.41 M(-1.0%)
-$1.09 B(-251.2%)
Mar 2021
-
-$226.67 M(-18.3%)
$717.98 M(-51.7%)
Dec 2020
$1.49 B(-224.8%)
-$277.39 M(-22.4%)
$1.49 B(+0.6%)
Sep 2020
-
-$357.39 M(-122.6%)
$1.48 B(-4.9%)
Jun 2020
-
$1.58 B(+191.1%)
$1.56 B(-565.5%)
Mar 2020
-
$542.52 M(-289.8%)
-$334.15 M(-72.0%)
Dec 2019
-$1.19 B(-13.6%)
-$285.80 M(+1.8%)
-$1.19 B(+31.6%)
Sep 2019
-
-$280.69 M(-9.5%)
-$905.82 M(+44.9%)
Jun 2019
-
-$310.18 M(-1.5%)
-$625.13 M(+98.5%)
Mar 2019
-
-$314.96 M
-$314.96 M
Dec 2018
-$1.38 B(+1018.9%)
-
-
Dec 2017
-$123.25 M
-
-

FAQ

  • What is Royalty Pharma annual cash flow from financing activities?
  • What is the all time high annual CFF for Royalty Pharma?
  • What is Royalty Pharma annual CFF year-on-year change?
  • What is Royalty Pharma quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Royalty Pharma?
  • What is Royalty Pharma quarterly CFF year-on-year change?
  • What is Royalty Pharma TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Royalty Pharma?
  • What is Royalty Pharma TTM CFF year-on-year change?

What is Royalty Pharma annual cash flow from financing activities?

The current annual CFF of RPRX is $361.14 M

What is the all time high annual CFF for Royalty Pharma?

Royalty Pharma all-time high annual cash flow from financing activities is $1.49 B

What is Royalty Pharma annual CFF year-on-year change?

Over the past year, RPRX annual cash flow from financing activities has changed by +$2.51 B (+116.81%)

What is Royalty Pharma quarterly cash flow from financing activities?

The current quarterly CFF of RPRX is -$257.96 M

What is the all time high quarterly CFF for Royalty Pharma?

Royalty Pharma all-time high quarterly cash flow from financing activities is $1.58 B

What is Royalty Pharma quarterly CFF year-on-year change?

Over the past year, RPRX quarterly cash flow from financing activities has changed by -$26.07 M (-11.24%)

What is Royalty Pharma TTM cash flow from financing activities?

The current TTM CFF of RPRX is $361.14 M

What is the all time high TTM CFF for Royalty Pharma?

Royalty Pharma all-time high TTM cash flow from financing activities is $1.56 B

What is Royalty Pharma TTM CFF year-on-year change?

Over the past year, RPRX TTM cash flow from financing activities has changed by +$2.51 B (+116.81%)